ArticleJournal of oncology2022

Clinical Efficacy of Antianlotinib Combined with Immune Checkpoint Inhibitors in the Treatment of Advanced Non-Small-Cell Lung Cancer and Its Effect on Serum VEGF, CEA, and SCC-Ag.

Linghui He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.